Good Feet

Item 7 lays out a substantial entry: initial franchise fee of $25,000, with total investment ranging $256,290 to $617,865 covering build-out, inventory from affiliates like Dr.'s Own, LLC, and store setup in high-traffic spots. Ongoing fees include 1.75% royalty, up to 3% brand fund (capped at the lesser of 3% or $1,975 monthly), and a $630 monthly technology fee—relatively lean compared to peers, potentially preserving more gross profit. Without Item 19, you're blind to average revenues or EBITDA across 254 franchise locations, a red flag since it forces reliance on anecdotes or seller claims; this opacity often signals variability in unit-level economics, especially in specialty retail competing with big-box alternatives.

System health shows momentum: from 210 locations in 2023 to 255 in 2024 (+21% growth), 37 projected new units, yet only 17 corporate stores hint at franchisor caution. Transfers hit 13 last year, possibly indicating resale activity from owners seeking exits, while just 4 SBA loans averaging $324,375 suggest limited bank financing appeal or few takers. The bankruptcy history (Item 20/21 context) underscores past strain, but recent expansion implies recovery—still, for a $500K+ play with no validated earnings, savvy investors will dig into FDD Items 20/21 for terminations/cancellations and validate via third-party validation before committing.